Fanconi Anemia
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
However, although FANCM contains a helicase domain with translocase activity, this is not required for its role in activating the FA pathway.
|
22279085 |
2012 |
Fanconi Anemia
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
However, genetic inactivation of FANCM in mouse and DT40 cells causes only a partial defect in the FA pathway activation, suggesting the existence of redundant DNA damage sensors.
|
21975120 |
2011 |
Fanconi Anemia
|
0.700 |
Biomarker
|
disease |
BEFREE |
In this review, we discuss the recent progress in the study of the FA pathway, such as the identification of new FANCM-binding partners and the identification of RAD51C and FAN1 (Fanconi-associated nuclease 1) as new FA pathway-related proteins.
|
20713514 |
2010 |
Fanconi Anemia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
These studies help to explain how FANCM (mutated in the human cancer predisposition syndrome, Fanconi's anaemia (FA)) co-ordinately regulates checkpoint signalling and replication fork progression.
|
20160754 |
2010 |
Fanconi Anemia
|
0.700 |
Biomarker
|
disease |
BEFREE |
Stabilizing and remodeling the blocked DNA replication fork: anchoring FANCM and the Fanconi anemia damage response.
|
20347418 |
2010 |
Fanconi Anemia
|
0.700 |
Biomarker
|
disease |
BEFREE |
FANCM (FA complementation group M), and its binding partner, FAAP24, anchor the multisubunit FA core complex to chromatin after DNA damage and may contribute to ICL-specific cellular response.
|
20670894 |
2010 |
Fanconi Anemia
|
0.700 |
Biomarker
|
disease |
BEFREE |
Moreover, a common phenotype of BS and FA cells-an elevated frequency of sister chromatid exchanges-was due to a loss of interaction of the two complexes through FANCM.
|
20064461 |
2009 |
Fanconi Anemia
|
0.700 |
Biomarker
|
disease |
BEFREE |
Because both mutants restored the formation of FANCD2 foci, we conclude that FANCM functions in an FA core complex-dependent and -independent manner.
|
19423727 |
2009 |
Fanconi Anemia
|
0.700 |
Biomarker
|
disease |
BEFREE |
This fact and novel data sustaining greater functional relevance of the three genes within the FA pathway prompted us to scrutinize all coding sequences and splicing sites of FANCI, FANCL and FANCM in 95 BRCA1/2-negative index cases from Spanish high-risk breast cancer families.
|
19737859 |
2009 |
Fanconi Anemia
|
0.700 |
Biomarker
|
disease |
BEFREE |
FANCM: A landing pad for the Fanconi Anemia and Bloom's Syndrome complexes.
|
20064455 |
2009 |
Fanconi Anemia
|
0.700 |
SusceptibilityMutation
|
disease |
CLINVAR |
Impaired FANCD2 monoubiquitination and hypersensitivity to camptothecin uniquely characterize Fanconi anemia complementation group M.
|
19423727 |
2009 |
Fanconi Anemia
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
Moreover, we find that the DNA translocase activity of FANCM, which is dispensable for FA pathway activation, is required for its role in ATR/Chk1 signaling.
|
18995830 |
2008 |
Fanconi Anemia
|
0.700 |
AlteredExpression
|
disease |
LHGDN |
Moreover, we find that the DNA translocase activity of FANCM, which is dispensable for FA pathway activation, is required for its role in ATR/Chk1 signaling.
|
18995830 |
2008 |
Fanconi Anemia
|
0.700 |
Biomarker
|
disease |
BEFREE |
Our data suggest an evolutionary link between Fanconi anemia-associated proteins and DNA repair; FANCM may act as an engine that translocates the Fanconi anemia core complex along DNA.
|
16116422 |
2005 |
Fanconi Anemia
|
0.700 |
SusceptibilityMutation
|
disease |
CLINVAR |
Our data suggest an evolutionary link between Fanconi anemia-associated proteins and DNA repair; FANCM may act as an engine that translocates the Fanconi anemia core complex along DNA.
|
16116422 |
2005 |
Fanconi Anemia
|
0.700 |
Biomarker
|
disease |
CTD_human |
Our data suggest an evolutionary link between Fanconi anemia-associated proteins and DNA repair; FANCM may act as an engine that translocates the Fanconi anemia core complex along DNA.
|
16116422 |
2005 |
MYELODYSPLASTIC SYNDROME
|
0.400 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Germline Genetic Predisposition to Hematologic Malignancy.
|
28297620 |
2017 |
MYELODYSPLASTIC SYNDROME
|
0.400 |
Biomarker
|
group |
HPO |
|
|
|
Pancytopenia
|
0.310 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Germline Genetic Predisposition to Hematologic Malignancy.
|
28297620 |
2017 |
Pancytopenia
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Human FANCM has been linked to Fanconi anemia, a syndrome characterized by cancer predisposition, developmental disorder, and bone marrow failure.
|
26341555 |
2015 |
Abnormality of radial ray
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility.
|
28837162 |
2018 |
Acute monocytic leukemia
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Germline Genetic Predisposition to Hematologic Malignancy.
|
28297620 |
2017 |
Leukemia, Myelocytic, Acute
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Germline Genetic Predisposition to Hematologic Malignancy.
|
28297620 |
2017 |
Miller Dieker syndrome
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Germline Genetic Predisposition to Hematologic Malignancy.
|
28297620 |
2017 |
Malignant Head and Neck Neoplasm
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
The germline variants in DNA repair genes in pediatric medulloblastoma: a challenge for current therapeutic strategies.
|
28376765 |
2017 |